MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Eden Research seeks approval for seed treatment in EU and UK

ALN

Eden Research PLC on Tuesday said that it has applied for its Ecovelex product to be approved in the EU, and also intends to pursue authorisation in the UK.

The Abingdon, England-based company, which develops and supplies sustainable solutions for crop protection, animal health and consumer products, is applying to have Ecovelex authorised, with Corteva Agriscience Inc as its distribution partner.

Ecovelex is a product for the seed treatment market, and is designed to replace conventional chemicals which are banned in the EU and UK. It creates an unpleasant taste or odour which repels birds, leaving seeds intact and birds unaffected.

Eden has been developing Ecovelex with Corteva Agriscience for the last three years, and is confident the product will be useful for farmers looking to meet consumer demands for more sustainable agriculture.

The authorisation of Ecovelex is likely to take some time. A review by Austria, which is acting as interzonal rapporteur, will take between 18 and 24 months, after which each EU state will either ratify the authorisation or request more information.

‘Eden’s collaboration with Corteva Agriscience over the past several years has been highly productive, and I am pleased to see the first real commercial benefits from these activities within reach,’ said Chief Executive Officer Sean Smith.

Eden Research shares were trading 0.6% higher at 3.47 pence each in London on Tuesday afternoon.

Copyright 2023 Alliance News Ltd. All Rights Reserved.